# Proteus Sustained Behavior Change Study

> **NCT01503008** · NA · WITHDRAWN · sponsor: **Proteus Digital Health, Inc.**

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** Proteus Sustained Behavior Change system
- **DRUG:** Regularly prescribed diabetes medicines (metformin, sulfonylureas, thiazolidinediones, DPP-IV inhibitors, alpha-glucosidase inhibitors)

## Key facts

- **NCT ID:** NCT01503008
- **Lead sponsor:** Proteus Digital Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01503008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01503008, "Proteus Sustained Behavior Change Study". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01503008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*